Fri, December 9, 2011
Thu, December 8, 2011
Wed, December 7, 2011
Tue, December 6, 2011
Mon, December 5, 2011
Sun, December 4, 2011
Fri, December 2, 2011
Thu, December 1, 2011
Wed, November 30, 2011
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ]: Market Wire
Alere Acquires Arriva Medical

Mylan Launches Generic Version of Caduet Tablets


//health-fitness.news-articles.net/content/2011/ .. -launches-generic-version-of-caduet-tablets.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Mylan Launches Generic Version of Caduet Tablets -- PITTSBURGH, Dec. 1, 2011 /PRNewswire/ --

Mylan Launches Generic Version of Caduet Tablets

[ ]

PITTSBURGH, Dec. 1, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: [ MYL ]) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Amlodipine Besylate and Atorvastatin Calcium Tablets, 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg, the generic version of Pfizer's Caduet® Tablets, which are used in the treatment of hypertension.

Caduet Tablets had U.S. sales of approximately $339 million for the 12 months ending Sept. 30, 2011, according to IMS Health. Mylan has started shipping this product.

Currently, Mylan has 163 ANDAs pending FDA approval representing $98.9 billion in annual sales, according to IMS Health. Forty-three of these pending ANDAs are potential first-to-file opportunities, representing $26.9 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit [ www.mylan.com ]. For more information about generic drugs, please visit [ www.ChoosingGenerics.com ].

 

 

 

SOURCE Mylan Inc.

[ Back to top ]

RELATED LINKS
[ http://www.mylan.com ]


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear